Worthy Christian News > World News > Success of experimental Alzheimer’s drug hailed as ‘historic moment’

Success of experimental Alzheimer’s drug hailed as ‘historic moment’

Thursday, September 29, 2022 | Tag Cloud Tags: Alzheimer, dementia, Worthy News | Learn about our FREE SYNDICATION Service | Receive Worthy News in your inbox! | Printer Friendly

(Worthy News) – An experimental drug has slowed the rate of decline in memory and thinking in people with early Alzheimer’s disease in what is being described as a “historic moment” for dementia treatment.

The cognition of Alzheimer’s patients given the drug, developed by Eisai and Biogen, declined by 27% less than those on a placebo treatment after 18 months. This is a modest change in clinical outcome but it is the first time any drug has been clearly shown to alter the disease’s trajectory.

“This is a historic moment for dementia research, as this is the first phase 3 trial of an Alzheimer’s drug in a generation to successfully slow cognitive decline,” said Dr Susan Kohlhaas, the director of research at Alzheimer’s Research UK. “Many people feel Alzheimer’s is an inevitable part of ageing. This spells it out: if you intervene early you can make an impact on how people progress.” [ Source: UK Guardian (Read More…) ]

New here? Receive the Worthy Brief and stay informed from a biblical perspective.

people are currently praying.

Worthy News reports from a biblical worldview with a commitment to accuracy, transparency, and editorial independence. Learn more about About Worthy News, our Editorial Standards, AI Use Policy, Ownership of Worthy News, News Tips and Corrections, and Worthy News Staff.

💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.

📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌

Discuss this article in our forums

Latest Worthy News

Trump Secretly Switched Planes Amid Iranian Assassination Threat

Swiss Government Rejects Push To Enshrine Strict Neutrality In Constitution

Indonesian, Pakistanis Among Six Killed In Houthi Ship Attack

Russian Strikes Kill 12 In Ukraine As Kyiv Reports North Korean Missiles

Former Jehovah’s Witness Turned Christian Publisher Wim de Goeij Dies At 64

Hungary Elects András Baka President As He Warns Against Revenge

Massachusetts Governor Signs Law Removing Specific Limits on Abortions After 24 Weeks

U.S. Golden Dome Missile Shield Passes Major Tests, but Funding Battle Threatens 2028 Deployment

Taliban Bars 2.4 Million Afghan Girls From School, Erasing Decades of Progress

Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.